Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome

National Medical Journal of China

Volumn 86, Issue 13, 2006, Pages 876-880

  Chu, Gui Lan ^a   Wang, Jing ^a   Xin, Yue ^a   Zheng, Jun ^a   Zheng, Rong Xiu ^a   Bi, Dao Zhuo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Neonatal diseases; Prophylactic administration; Pulmonary surfactants; Respiratory distress syndrome

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; OXYGEN; PORACTANT;

AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BIRTH WEIGHT; BLOOD GAS PARAMETERS; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; GESTATIONAL AGE; HIGH RISK INFANT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT MORTALITY; MICROBUBBLE; MORBIDITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PERINATAL PERIOD; PREMATURITY; RADIOLOGICAL PROCEDURES; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

BIOLOGICAL PRODUCTS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY FUNCTION TESTS;

EID: 33646055465     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Suresh GK, Soll RF. Exogenous surfactant therapy in newborn infants. Ann Acad Med Singapore, 2003, 32: 335.
2. Fiori HH, Varela I, Gusto AL, et al. Stable microbubble test and click test to predict respiratory distress syndrome in preterm infants not requiring ventilated at birth. J Perinat Med, 2003, 31: 509.
3. Teeratakulpisarn J, Taksaphan S, Pengsaa K, et al. Prediction of idiopathic respiratory distress syndrome by the stable microbubble test on gastric aspirate. Pediatr Pulmonol, 1998, 25: 383.
4. Chinese source. 2004. 422-423.
5. Halliday HL. History of surfactant from 1980. Biol Neonate, 2005, 87: 317-22.
6. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev, 2001: CD000144.
7. Milligan DW, Ainsworth SB. Animal-derived or synthetic surfactant for the treatment of neonatal respiratory distress syndrome: a review. Acta Paediatr, 2001, 90 Suppl: 25.
8. Bevilacqua G, Parmigiani S, Robertson B. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med, 1996, 24: 609.
9. Zola EM, Gunkel JH, Chan RK, et al. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr, 1993, 122: 453.
10. Robertson B. Pathology of neonatal surfactant deficiency. Perspect Pediatr Pathol, 1987, 11: 6.
11. Horbar JD, Carpenter JH, Buzas J, et al. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based? Pediatrics, 2004, 113: 1593.
12. Bevilacqua G, Parmigiani S, Observes Group. An observational study of surfactant treatment in infants of 23-30 weeks'gestation: comparison of prophylaxis and early rescue. J Matern Fetal Neonatal Med, 2003, 14: 197-204.
13. Dunn MS, Shennan AT, Zayack D, et al. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics, 1991, 87: 377.